Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery
NCT ID: NCT00500227
Last Updated: 2019-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
55 participants
OBSERVATIONAL
2007-09-30
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiovascular Outcome After Surgery or Somatostatin Analogues
NCT00615004
Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery
NCT05149495
Somatuline Predictive Factors in Acromegaly and NET
NCT01840449
Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues
NCT02427295
Non Interventional Post Marketing Programme in Acromegaly
NCT00747500
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who have received radiation therapy or will receive it during the observational study period
* Patients who are being treated, or in whom treatment is anticipated, with either a dopaminergic agonist or a growth hormone receptor antagonist
* Patients with a history of hypersensitivity to somatostatin analogues
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ipsen
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ipsen Medical Director
Role: STUDY_DIRECTOR
Ipsen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital "Juan Canalejo"
A Coruña, , Spain
Hospital General Universitari d'Alacant
Alicante, , Spain
Hospital de Cruces
Barakaldo, , Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, , Spain
Hospital General de la Vall d´Hebron
Barcelona, , Spain
Hospital Clínic i Provincial de Barcelona
Barcelona, , Spain
Hospital "Mútua de Terrassa"
Barcelona, , Spain
Hospital Prínceps d'Espanya
Barcelona, , Spain
Hospital Universitario de Getafe
Getafe, , Spain
Complejo Hospitalario de León. Hospital Virgen Blanca.
León, , Spain
Complejo Hospitalario Xeral-Calde de Lugo
Lugo, , Spain
Hospital de La Princesa
Madrid, , Spain
Hospital "Ramón y Cajal"
Madrid, , Spain
Hospital Universitario Puerta de Hierro
Madrid, , Spain
Fundación Jiménez Díaz
Madrid, , Spain
Hospital Clínico de Madrid
Madrid, , Spain
Hospital Universitario "12 de Octubre"
Madrid, , Spain
Hospital Universitario "La Paz"
Madrid, , Spain
Complexo Hospitalario de Orense
Ourense, , Spain
Hospital "Son Dureta"
Palma de Mallorca, , Spain
Hospital de Navarra
Pamplona, , Spain
Hospital Nuestra Señora de la Candelaria
Santa Cruz de Tenerife, , Spain
Hospital "Marqués de Valdecilla"
Santander, , Spain
Hospital Clínico Universitario de Santiago
Santiago de Compostela, , Spain
Hospital "Joan XXIII"
Tarragona, , Spain
Hospital Clínico Universitario de Valencia
Valencia, , Spain
Hospital Clínico de Valladolid
Valladolid, , Spain
Complejo Hospitalario Xeral-Cies de Vigo
Vigo, , Spain
Hospital "Miguel Servet"
Zaragoza, , Spain
Hospital Clínico Universitario "Lozano Blesa"
Zaragoza, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A-92-52030-728
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.